Difference between revisions of "Aldesleukin (Proleukin)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "Template to be used for chemotherapies: (strive for minimalism, focus on regimens) ==General information== Class: Recombinant IL-2, immune system activation<ref name="insert">[h...")
 
m
Line 1: Line 1:
Template to be used for chemotherapies:
 
(strive for minimalism, focus on regimens)
 
 
 
==General information==
 
==General information==
 
Class: Recombinant IL-2, immune system activation<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/proleukin.pdf Aldesleukin package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/aldesleukin.pdf Aldesleukin package insert (locally hosted backup)]</ref>
 
Class: Recombinant IL-2, immune system activation<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/proleukin.pdf Aldesleukin package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/aldesleukin.pdf Aldesleukin package insert (locally hosted backup)]</ref>
Line 10: Line 7:
 
==Patient drug information==
 
==Patient drug information==
 
*[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]</ref>
*Side effects discussed for informed consent
 
  
 
==Regimens==
 
==Regimens==

Revision as of 20:24, 15 November 2011

General information

Class: Recombinant IL-2, immune system activation[1][2]
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].

Patient drug information

Regimens

Standard format will be:
<acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease)

References